Nan Shan Life Insurance Co. Ltd. Has $27.87 Million Stock Holdings in CVS Health Corporation $CVS

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Nan Shan Life Insurance Co. Ltd. trimmed its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 6.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 411,413 shares of the pharmacy operator's stock after selling 30,344 shares during the quarter. Nan Shan Life Insurance Co. Ltd.'s holdings in CVS Health were worth $27,873,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Whitebox Advisors LLC acquired a new stake in CVS Health in the 4th quarter valued at approximately $249,000. Jennison Associates LLC increased its position in CVS Health by 503.8% in the 1st quarter. Jennison Associates LLC now owns 1,896,341 shares of the pharmacy operator's stock valued at $128,477,000 after acquiring an additional 1,582,257 shares during the period. Cerity Partners LLC increased its position in CVS Health by 25.0% in the 1st quarter. Cerity Partners LLC now owns 648,266 shares of the pharmacy operator's stock valued at $43,920,000 after acquiring an additional 129,535 shares during the period. Bank of New York Mellon Corp increased its position in CVS Health by 2.1% in the 1st quarter. Bank of New York Mellon Corp now owns 8,981,262 shares of the pharmacy operator's stock valued at $608,481,000 after acquiring an additional 183,813 shares during the period. Finally, Fairfax Financial Holdings Ltd. Can acquired a new stake in CVS Health in the 4th quarter valued at approximately $121,742,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CVS has been the topic of several analyst reports. UBS Group upgraded CVS Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $67.00 to $79.00 in a research report on Monday, August 18th. Baird R W upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 14th. Robert W. Baird upgraded CVS Health from a "neutral" rating to an "outperform" rating and lifted their price target for the company from $71.00 to $82.00 in a research report on Thursday, August 14th. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Cowen reiterated a "buy" rating on shares of CVS Health in a research report on Monday, August 4th. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $76.67.

CVS Health Price Performance

Shares of CVS traded down $0.2560 during trading hours on Friday, hitting $71.1740. 6,982,068 shares of the company were exchanged, compared to its average volume of 8,748,738. The company has a market capitalization of $90.27 billion, a PE ratio of 19.88, a PEG ratio of 0.79 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The firm has a fifty day simple moving average of $65.50 and a 200-day simple moving average of $65.11. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company's revenue was up 8.4% compared to the same quarter last year. During the same period last year, the company posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.7%. CVS Health's dividend payout ratio (DPR) is currently 74.30%.

Insider Buying and Selling at CVS Health

In related news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction dated Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director directly owned 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.